SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-054896
Filing Date
2018-10-12
Accepted
2018-10-12 16:42:14
Documents
2
Period of Report
2018-10-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1561
2 POA DOCUMENT poa.txt EX-24.3_813442 3043
  Complete submission text file 0001209191-18-054896.txt   5957
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Issuer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1333 S SPECTRUM BLVD #100 CHANDLER AZ 85286
Business Address
Nance Mark E (Reporting) CIK: 0001755882 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35902 | Film No.: 181120633